Matthew A. Pearson

Federal Circuit: The Term 'Clinically Proven Effective' Amount Does Not Impart Patentability Over Prior Art For Claims That Also Recite Specific Numerical Dosages

US Seeks Comments On WIPO Genetic Resources Treaty

Federal Circuit: Patent Term Adjustment Results In Invalidity On Obviousness-Type Double Patenting Grounds

Federal Circuit Decision Provides Opening For Preparation Methods In Diagnostic Space, But Not For Diagnostic Claims

Bases, And Esters, And Salts, Oh My! Limits On PTE Benefits Provide A Drug Applicant With A Winning Non-Infringement Position

Federal Circuit Partially Clarifies Obviousness-Type Double Patenting Law In Two Opinions Released The Same Day